ArticleBMC research notes2025
Examining the role of Notch signaling in dysplastic lung repair.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSevere lung injury promotes the appearance of ectopic basal cells in the alveolar space. Since these cells appear to contribute to barrier restoration but demonstrate very inefficient differentiation into normal alveolar epithelium, this represents a dysplastic repair response. Prior work demonstrated the necessity of Notch signaling for expansion of these cells directly as well as indirectly via interactions with activated fibroblasts, but the original studies largely relied on γ-secretase inhibitors which lack specificity for the Notch pathway. Here we utilize a genetic, dominant-negative approach to more carefully assess the role of Notch signaling in these prior studies.
resultsUsing transgenic mice expressing a dominant-negative (dn) MAML construct, our data supports the interpretation that Notch signaling to dysplastic cells impacts their expansion post-influenza. However, dnMAML expression at later time points did not appreciably increase differentiation into alveolar epithelial cells. These results confirm earlier studies and reiterate the advantages of genetic approaches to directly inhibit Notch over less specific pharmacological approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.